Serum Immunoglobulin free light chains as markers of disease burden and response to treatment in patients with Waldenstrom's macroglobulinemia

8617 Background: Waldenstrom’s macroglobulinemia (WM) is a B-cell malignancy characterized by the presence of a serum monoclonal IgM protein, which is used to monitor both disease burden and respon...